CEACAM5 and colorectal carcinoma: Since almost 30% of colorectal carcinomas do not produce CEA [72], an increasing amount of research has been performed in recent years on new types of circulating tumor biomarkers, such as circulating tumor cells (CTCs), tumor DNA (ctDNA) and microRNA (miRNA) [73].